about the fitted regression line
was somewhat greater for genotoxic carcinogens than for nongenotoxic carcinogens, implying that this relationship is weaker for genotoxic carcinogens as compared to nongenotoxic carcinogens. The authors suggested that this is consistent with the hypothesis that carcinogenic effects observed at the MTD are mediated to a certain extent by toxicity, and that the larger variability exhibited by genotoxic carcinogens is because of their ability to induce carcinogenic effects by direct damage to genetic material. This does not imply that toxicity does not play a role in the induction of tumors by mutagenic chemicals; rather it is the inability of nongenotoxic agents to interact directly with DNA that leads to this difference.
Goodman & Wilson (1992) also examined a second set of 245 compounds which had tested positive in various Salmonella strains (cf. Zeiger et al., 1988). Since no significant differences in the variablity of fitted regressions lines were noted within three categories of mutagenic potency, it did not appear possible to further characterize the variability in the potency of genotoxic carcinogens relative to the MTD on the basis of genotoxic potency.
4. Prediction of the TD50
4.1 Predictions Based on the MDT
The high correlation between the TD50 and the MTD demonstrated in section 3 suggests that the TD50 may be predicted from the MTD. To explore this possibility, we fit the linear regression model
to data on the 191 chemical carcinogens considered previously in section 2.3. Here, e represents a random error term which is assumed to be normally distributed with mean zero and variance s2, and a and b are parameters that can be estimated using ordinary least squares. Separate